Last reviewed · How we verify
LENUS Pro® Study (LPS-II) - Observation Study With Implantable Medication Pump for Intravenous REMODULIN® (Treprostinil) Therapy in Patients With Pulmonary Arterial Hypertension
The study is designed as a non-interventional, multicenter, prospective single-arm study to observe the therapy with REMODULIN (Treprostinil) applicated by an implantable pump in patients with pulmonary arterial hypertension (PAH).
Details
| Lead sponsor | University Medicine Greifswald |
|---|---|
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | 2020-03 |
| Completion | 2021-12 |
Conditions
- Pulmonary Arterial Hypertension
- PAH
Interventions
- Treprostinil via implanted pump
Primary outcomes
- Recovery of clinical stability criteria — Baseline and after 6 months intravenous therapy with Treprostinil
to achieve "low-risk-status"
Countries
Germany